← Back to all signals
RESEARCH PAPER ANALYSIS

Elevation of White Blood Cell Count After G-CSF-Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies.

AI interpretation is pending for this paper.

Open original publication →
PMID41238192
JournalTransplantation and cellular therapy
Publication Date2025-11-17
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Granulocyte colony-stimulating factor (G-CSF) enhances the cytotoxicity of cytarabine (Ara-C) against myeloid leukemia cells, and G-CSF-combined conditioning regimens have been adopted in single-unit cord blood transplantation (CBT) at our institution. However, it remains unclear whether the degree of white blood cell (WBC) elevation during G-CSF administration predicts transplant outcomes. METHODS: We retrospectively analyzed 175 adult patients with myeloid malignancies who underwent first single-unit CBT with myeloablative conditioning (total body irradiation 12 Gy, high-dose Ara-C with G-CSF, and cyclophosphamide) at our institution between 2000 and 2024. The G-CSF priming effect was evaluated by the ratio and absolute difference in WBC counts before and after G-CSF administration. Patients were stratified into higher and lower groups based on receiver operating characteristic curve-derived cutoffs (WBC ratio ≥2.0, WBC difference ≥4.0 × 10⁹/L). RESULTS: Disease-free survival (DFS) was significantly higher in patients with a higher WBC ratio (71.5% versus 53.6% at 5 years, P = .001) and higher WBC difference (75.9% versus 57.9% at 5 years, P = .0009). In multivariate analysis, a higher WBC ratio was independently associated with improved DFS (HR, 0.58, 95% CI, 0.36 to 0.96, P = .035) and reduced relapse (HR, 0.46, 95% CI, 0.23 to 0.92, P = .028). A higher WBC difference was also associated with reduced relapse (HR, 0.44, 95% CI, 0.19 to 0.99, P = .049). Neither WBC parameter was associated with non-relapse mortality or engraftment. Notably, the beneficial effects of higher WBC ratio and difference were confined to patients with high or very high risk of the refined Disease Risk Index. CONCLUSIONS: Elevation of WBC counts during G-CSF-combined conditioning predicts favorable outcomes after single-unit CBT, particularly in patients with high-risk myeloid malignancies.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Global Trends in Sun Safety and Skin Cancer Prevention Education Among Adolescents: A Bibliometric Analysis. Cureus 58.0 2 Development and Validation of an Interpretable Machine Learning Model for Predicting Early Pulmonary Metastasis Risk in Osteosarcoma. Cancer medicine 66.3 3 Financial toxicity among families of children with cancer: a qualitative systematic review and meta-aggregation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 77.52 4 Evaluation and Management of Suspected Mucinous Adnexal Masses in Children and Adolescents: A Practice-Focused Review. Journal of pediatric and adolescent gynecology 59.0 5 Acute Myeloid Leukemia Involving the Skin. Journal of cutaneous pathology 54.0 6 [Analysis and prediction study on the burden of malignant neoplasms of bone and articular cartilage in East Asian countries from 1990 to 2023]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 40.9 7 Retinoblastoma Metastatic to Bone: Case Series and Literature Review. Journal of radiology case reports 53.4 8 Pediatric Plantar Malignant Melanoma, Subungual Melanoma, and Spitzoid Melanoma: A Case Series of Rare Pediatric Melanomas. The Journal of clinical and aesthetic dermatology 48.5 9 Inborn errors of immunity and mortality: 10 years of single-center experience. Allergologia et immunopathologia 60.5 10 Regional Diversity of Human Papillomavirus Genotypes in Southeastern Brazil: Implications for Cervical Cancer Screening. Journal of medical virology 61.0 11 Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis. Hematological oncology 74.52 12 Knowledge, attitudes, and practices regarding Helicobacter pylori-induced gastric ulcers and cancers among Saudi residents: a nationwide web-based survey. Frontiers in public health 70.4 13 Adult psychological outcomes among women with different adolescent PCOS presentations. Frontiers in endocrinology 59.5 14 Computational insights into synergistic mechanisms of PD-901 and 5-azacitidine targeting PTPN11 (SHP2) E76K mutation in juvenile myelomonocytic leukemia. Frontiers in bioinformatics 62.85 15 Clinical evidence and biological mechanisms linking obesity to adverse outcomes in pediatric and adolescent acute lymphoblastic leukemia. Frontiers in oncology 68.95 16 [Comparison of inpatient disease statistics based on two coding rules]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 61.9 17 Serum HMGB3 and PCSK9 Levels as Predictors of Early Treatment Response in Pediatric Mycoplasma pneumoniae Pneumonia: A Single-Center Prospective Cohort Study. International journal of general medicine 79.26 18 Prevalence and penetrance of heritable retinoblastoma in two adult population cohorts: implications for genomic newborn screening. European journal of human genetics : EJHG 65.5 19 A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators. Journal of cancer survivorship : research and practice 65.9 20 Perinatal Characteristics of Japanese Children With Infantile Hemangioma: A Questionnaire-Based Case-Control Study. The Journal of dermatology 67.0 21 Efficacy of celecoxib and methotrexate-vinblastine regimen in desmoid-type fibromatosis: A retrospective cohort study. Medicine 76.0 22 The safety and efficacy of different anti-tuberculosis regimens containing Lzd for RR/MDR/Pre-XDR-TB patients in China. Medicine 68.2 23 Nursing care of a pediatric patient with anti-NMDAR encephalitis complicated by secondary epilepsy: A case report. Medicine 61.1 24 Cardiac involvement in neurofibromatosis type 1: real-world baseline and follow-up findings from a tertiary single-center cohort. European journal of pediatrics 62.9 25 Multimodal clinical-radiomic-deep learning model for preoperative classification of pediatric pineal region tumors. Neuroradiology 70.4 26 Precision medicine for pediatric gliomas. Current opinion in oncology 80.34 27 Parental distress - a predictor of treatment adherence in pediatric neuroblastoma: a cross-sectional study of chinese families. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 62.24 28 Integrating optimal patient-centered care: patient- and family-reported experiences after complex treatment for rare diseases. World journal of pediatrics : WJP 63.94 29 [Guidelines for the diagnosis and treatment of hemophagocytic lymphohistiocytosis (2026 edition)]. Zhonghua yi xue za zhi 73.84 30 Cranial MRI in Girls With Central Precocious Puberty: Clinical Characteristics and Predictors of Abnormal Findings. Saudi medical journal 69.8 31 Diffuse midline glioma, H3 K27-altered, forming a suprasellar mass: A case report. Radiology case reports 51.9 32 Integrating immunophenotyping and morphology in the diagnosis of acute leukemia at the National Oncology Center, Sana'a, Yemen. The Libyan journal of medicine 61.0
PATIENT-FRIENDLY SUMMARY

Elevation of White Blood Cell Count After G-CSF-Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic